JCPyV-specific T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JCPyV-specific T cell therapy, covering 2022-09-16 to 2022-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML [Phase 2]